SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-24-028642
Filing Date
2024-06-03
Accepted
2024-06-03 17:24:20
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 ny20025434x5_s3.htm S-3 546674
2 EXHIBIT 1.3 ny20025434x5_ex1-3.htm EX-1.3 208291
3 EXHIBIT 4.3 ny20025434x5_ex4-3.htm EX-4.3 553645
4 EXHIBIT 4.4 ny20025434x5_ex4-4.htm EX-4.4 520966
5 EXHIBIT 5.1 ny20025434x5_ex5-1.htm EX-5.1 32760
6 EXHIBIT 23.1 ny20025434x5_ex23-1.htm EX-23.1 1907
7 EXHIBIT 107 ny20025434x5_ex107.htm EX-FILING FEES 47096
8 logo_elicio.jpg GRAPHIC 33082
9 logo_jones.jpg GRAPHIC 25551
10 ny20025434x5_ex5-1img01.jpg GRAPHIC 13477
  Complete submission text file 0001140361-24-028642.txt   2011561
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279925 | Film No.: 241015035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)